North End Cyclery Ltd.

3104 ARCTIC AVE
VIRGINIA BEACH, VA 23451

eric@northendbikes.com

Us citizens not that bothered by Mad Cow disease Only a small %age of U.

Us citizens not that bothered by Mad Cow disease Only a small %age of U.S http://www.cialissuomi.com/erektiohairioita.html . Beef consumers changed their buying practices after December’s Bovine Spongiform Encephalopathy-positive case in Washington, according to a recently available national study from Colorado Condition University Cooperative Extension. The study also suggests that consumers put a higher importance on BSE – – or mad cow – – tests of beef in the meals supply when compared to emphasis they put on other traits – cost, natural or grass-fed traceability and beef of the merchandise through the meals supply system.

Amgen announces European approval of Prolia Amgen Inc. Prolia has been approved in every 27 European Union member Norway plus claims, Liechtenstein and Iceland. The European acceptance of Prolia marks the 1st approval of the merchandise worldwide. ‘The European authorization of Prolia is definitely a substantial medical advance for sufferers with bone loss conditions,’ said Will Dere, senior vice president and worldwide chief medical officer at Amgen. ‘Specifically, we think that Prolia will offer sufferers with postmenopausal osteoporosis at increased risk for fracture an important alternative to current treatments. Prolia reduces the risk of fracture through a easy injection given every six months. Amgen is usually proud to create this new treatment open to doctors and their patients.’ Related StoriesCornell biomedical engineers develop 'super organic killer cells' to destroy malignancy cells in lymph nodesViralytics enters into scientific trial collaboration contract with MSDMD Anderson research reveals why chemotherapy drugs not effective for most pancreatic cancer patientsThe advertising authorization for Prolia comprises data from six Stage 3 trials, including two pivotal Phase 3 studies with fracture endpoints in the prostate and osteoporosis cancer tumor settings, which demonstrated that Prolia administered as a 60mg subcutaneous injection every half a year decreases the incidence of fractures.